The 223A>G polymorphism of the leptin receptor gene and lipid-lowering efficacy of simvastatin in Chinese patients with coronary heart disease

Author： Sun Yan-Ming   Wang Lan-Feng   Li Jia   Li Zhu-Qin   Pan Wei  

Publisher： Springer Publishing Company

ISSN： 0031-6970

Source： European Journal of Clinical Pharmacology, Vol.65, Iss.2, 2009-02, pp. : 157-161

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pharmacogenetics of apolipoprotein E gene during lipid-lowering therapy: lipid levels and prevention of coronary heart disease

By Nieminen Tuomo   Käähöönen Mika   Viiri Leena E   Gröönroos Paula   Lehtimääki Terho  

Pharmacogenomics, Vol. 9, Iss. 10, 2008-10 ,pp. : 1475-1486

Future Medicine

Access to resources Recommend Favorite

Cost Effectiveness of Intensive Lipid-Lowering Treatment for Patients with Congestive Heart Failure and Coronary Heart Disease in the US

By Rosen Virginia M.  

PharmacoEconomics, Vol. 28, Iss. 1, 2010-01 ,pp. : 47-60

Adis International

Access to resources Recommend Favorite

Editorial:primary Prevention of Coronary Heart Disease with Lipid Lowering Therapy

By Bernini F.   Paoletti R.  

Pharmacological Research, Vol. 35, Iss. 3, 1997-03 ,pp. : 167-167

Academic Press

Access to resources Recommend Favorite

Comparison of the Lipid-Lowering Effects of Fluvastatin, Lovastatin and Simvastatin in Patients with Hyperlipoproteinaemia : An Internally Controlled Clinical Study

By Paragh G.   Balogh Z.   Kakuk G.   Kovacs P.  

Clinical Drug Investigation, Vol. 18, Iss. 3, 1999-09 ,pp. : 209-215

Adis International

Access to resources Recommend Favorite

Lipid-lowering therapy in acute coronary syndromes

By  

Inpharma, Vol. 1, Iss. 1283, 2001-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite